Shanxi Jinbo Bio pharmaceutical Co (BJSE:920982) Cyclically Adjusted FCF per Share: ¥1.22 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920982 Shanxi Jinbo Bio pharmaceutical Co Ltd BJSE:920982
78 GF Score
Price ¥120.99
GF Value ¥251.07
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Shanxi Jinbo Bio pharmaceutical Co Cyclically Adjusted FCF per Share?

Shanxi Jinbo Bio pharmaceutical Co BJSE:920982 78 Cyclically Adjusted FCF per Share is ¥1.22 as of Jun. 2026. GuruFocus rates BJSE:920982 with a GF Score™ of 78/100 and a GF Value™ of ¥251.07 (Possible Value Trap). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Shanxi Jinbo Bio pharmaceutical Co's adjusted free cash flow per share for the three months ended in Jun. 2026 was ¥0.828. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥1.22 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-30), Shanxi Jinbo Bio pharmaceutical Co's current stock price is ¥120.99. Shanxi Jinbo Bio pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was ¥1.22. Shanxi Jinbo Bio pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 99.17.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shanxi Jinbo Bio pharmaceutical Co was 223.30. The lowest was 96.89. And the median was 148.00.


Shanxi Jinbo Bio pharmaceutical Co  (BJSE:920982) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shanxi Jinbo Bio pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=120.99/1.22
=99.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shanxi Jinbo Bio pharmaceutical Co was 223.30. The lowest was 96.89. And the median was 148.00.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Shanxi Jinbo Bio pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms


Shanxi Jinbo Bio pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Shanxi Jinbo Bio pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanxi Jinbo Bio pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Shanxi Jinbo Bio pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.06

Shanxi Jinbo Bio pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1.06 1.16 1.22

BJSE:920982 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Shanxi Jinbo Bio pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanxi Jinbo Bio pharmaceutical Co Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanxi Jinbo Bio pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanxi Jinbo Bio pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


BJSE:920982
78GF Score
Shanxi Jinbo Bio pharmaceutical Co Ltd BJSE:920982
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanxi Jinbo Bio pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanxi Jinbo Bio pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.828/116.0564*116.0564
=0.828

Current CPI (Jun. 2026) = 116.0564.

Shanxi Jinbo Bio pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.000 99.500 0.000
201512 0.000 100.600 0.000
201606 0.000 101.400 0.000
201612 0.000 102.600 0.000
201703 -0.073 103.200 -0.082
201706 0.162 103.100 0.182
201709 -0.101 104.100 -0.113
201712 0.361 104.500 0.401
201803 0.033 105.300 0.036
201806 -0.277 104.900 -0.306
201809 -0.307 106.600 -0.334
201812 0.384 106.500 0.418
201903 -0.068 107.700 -0.073
201906 -0.180 107.700 -0.194
201909 -0.318 109.800 -0.336
201912 0.321 111.200 0.335
202006 0.000 110.400 0.000
202012 0.000 111.500 0.000
202103 0.182 112.662 0.187
202106 -0.222 111.769 -0.231
202109 -0.401 112.215 -0.415
202112 -0.132 113.108 -0.135
202203 -0.109 114.335 -0.111
202206 0.038 114.558 0.038
202209 0.246 115.339 0.248
202212 0.113 115.116 0.114
202303 -0.231 115.116 -0.233
202306 0.272 114.558 0.276
202309 0.365 115.339 0.367
202312 0.789 114.781 0.798
202403 0.626 115.227 0.631
202406 1.998 114.781 2.020
202409 1.301 115.785 1.304
202412 1.381 114.893 1.395
202503 0.213 115.116 0.215
202506 1.176 114.907 1.188
202509 0.999 115.471 1.004
202512 -0.127 115.832 -0.127
202603 1.110 116.303 1.108
202606 0.828 116.056 0.828

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥1.22 mean?
Shanxi Jinbo Bio pharmaceutical Co (BJSE:920982) has a Cyclically Adjusted FCF per Share of ¥1.22 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shanxi Jinbo Bio pharmaceutical Co and its competitors.
Is Shanxi Jinbo Bio pharmaceutical Co's Cyclically Adjusted FCF per Share too high?
Shanxi Jinbo Bio pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥1.22. Overall, Shanxi Jinbo Bio pharmaceutical Co has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanxi Jinbo Bio pharmaceutical Co's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Shanxi Jinbo Bio pharmaceutical Co's Cyclically Adjusted FCF per Share of ¥1.22 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shanxi Jinbo Bio pharmaceutical Co and its competitors. Shanxi Jinbo Bio pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanxi Jinbo Bio pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanxi Jinbo Bio pharmaceutical Co (BJSE:920982) is currently considered Possible Value Trap. The stock's GF Value™ is ¥251.07, compared to a current price of ¥120.99 — trading 51.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥1.22. Shanxi Jinbo Bio pharmaceutical Co's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Shanxi Jinbo Bio pharmaceutical Co (BJSE:920982), the current Cyclically Adjusted FCF per Share is ¥1.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanxi Jinbo Bio pharmaceutical Co (BJSE:920982) Overvalued in 2026?

Based on GuruFocus' analysis, Shanxi Jinbo Bio pharmaceutical Co stock appears to be undervalued. The current stock price of ¥120.99 is trading 51.8% below its estimated GF Value™ of ¥251.07. GuruFocus considers Shanxi Jinbo Bio pharmaceutical Co to be Possible Value Trap.

Key valuation signals for BJSE:920982:

  • Cyclically Adjusted FCF per Share: ¥1.22
  • GF Value™: ¥251.07 vs. price of ¥120.99 (51.8% below fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the BJSE:920982 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanxi Jinbo Bio pharmaceutical Co Business Description

Address No. 18, Jinbo Street, Tanghuai Park, Comprehensive Reform Demonstration Zone, Shanxi, Taiyuan, CHN, 030032
Shanxi Jinbo Bio pharmaceutical Co Ltd is engaged in research & development, production and sales of various medical devices and functional skin care products with recombinant collagen products and anti-HPV biological protein products as the core.
78GF Score

Get the complete analysis for BJSE:920982

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥120.99
Price
¥251.07
GF Value